A masked fan unplugged a video assistant referee (VAR) monitor in a German second division match on Sunday as the referee was went to the pitchside screen to check a penalty award. The incident occurred at the end of the first half of Preussen Munster's 2-1 home defeat by Hertha Berlin in Bundesliga 2. VAR had intervened and referee Felix Bickel was asked to review the incident on a pitchside moni...
A masked fan unplugged a video assistant referee (VAR) monitor in a German second division match on Sunday as the referee was went to the pitchside screen to check a penalty award. The incident occurred at the end of the first half of Preussen Munster's 2-1 home defeat by Hertha Berlin in Bundesliga 2. VAR had intervened and referee Felix Bickel was asked to review the incident on a pitchside monitor, but found the screen blank. "A masked spectator from the active fan section illegally entered the pitch and unplugged the technical equipment," Preussen Munster said in a statement., external With Bickel unable to make the call, the decision was left to the VAR official Katrin Rafalski in Cologne, ruling that it was a foul and for Bickel to award a penalty, which Hertha scored. "Preussen Munster regrets the incident and will do everything in its power to identify and bring the perpetrator(s) to justice," the club added, "Furthermore, immediate measures have been taken to prevent similar incidents in the future. Initial findings indicate that this was a planned action - a banner to that effect was displayed in the home section shortly after the technical malfunction." German media reported that a banner reading "Pull the plug on VAR" was displayed.
South Korean equities fell, extending last week’s losses, as geopolitical tensions continued to escalate in the Middle East and oil surged on reduced production due to the Iran war. The Kospi plunged as much as 6.7%, after sinking by 11% last week. Chip heavyweights Samsung Electronics Co. and SK Hynix Inc. were again the biggest drags on the benchmark index, declining around 7% each.
South Korean equities fell, extending last week’s losses, as geopolitical tensions continued to escalate in the Middle East and oil surged on reduced production due to the Iran war. The Kospi plunged as much as 6.7%, after sinking by 11% last week. Chip heavyweights Samsung Electronics Co. and SK Hynix Inc. were again the biggest drags on the benchmark index, declining around 7% each.
Conflict in the Middle East continues to lead many of the front pages. Iranian clerics named Ayatollah Ali Khamenei's son Mojtaba Khamenei as the new Supreme Leader, in what the Times describes as a "challenge to Trump". It cites the US President's previous comments that the 56-year-old "would not be an acceptable new leader" of Iran. Mojtaba Khamenei "may already be injured" following recent US-I...
Conflict in the Middle East continues to lead many of the front pages. Iranian clerics named Ayatollah Ali Khamenei's son Mojtaba Khamenei as the new Supreme Leader, in what the Times describes as a "challenge to Trump". It cites the US President's previous comments that the 56-year-old "would not be an acceptable new leader" of Iran. Mojtaba Khamenei "may already be injured" following recent US-Israeli strikes, the paper adds.
Key Points The company's "growth portfolio" is offsetting declines in "legacy" treatments. It also showed marked progress in two of its developmental programs. 10 stocks we like better than Bristol Myers Squibb › Ever-busy global pharmaceutical company Bristol Myers Squibb (NYSE: BMY) had quite an active February. Since much of the news coming from it was positive, investors were largely bullish o...
Key Points The company's "growth portfolio" is offsetting declines in "legacy" treatments. It also showed marked progress in two of its developmental programs. 10 stocks we like better than Bristol Myers Squibb › Ever-busy global pharmaceutical company Bristol Myers Squibb (NYSE: BMY) had quite an active February. Since much of the news coming from it was positive, investors were largely bullish on its future, even after price cuts to its No. 1 drug kicked in. This optimism was reflected in a share price rise of over 13% over the month. Growth where it counts Near the start of February, Bristol Myers Squibb published its final earnings report for 2025. It managed to grow its fourth-quarter revenue, albeit modestly, by 1% year over year to $12.5 billion. We can't say the same for net income not under generally accepted accounting principles (GAAP), which sank at a double-digit rate of almost 24% to $2.6 billion, or $1.26 per share. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » That sounds a bit scary, but it's the latest chapter in a story that's been playing out for the healthcare giant for some time. It still derives much of its coin from the so-called "legacy portfolio," its collection of medicines that have either hit their patent cliffs or are rapidly approaching them. This includes the above-mentioned drug, blood thinner Eliquis, the net profits for which are shared with the company's big pharma partner Pfizer. In the quarter, legacy's revenue dived by 15% to slightly more than $5.1 billion. The contrast with Bristol Myers Squibb's very promising "growth portfolio" of drugs that have some time before the cliff looms is stark. Led by blockbuster cancer drug Opdivo, growth's growth (sorry) for the quarter was 16%, rising to nearly $7.4 billion. Regardless, the company easily exceeded the cons...
Key Points The Federal Reserve cut its key rates twice during the period. It probably won't repeat that move anytime soon, however. 10 stocks we like better than UWM Holdings › Investors in mortgage lender UWM Holdings (NYSE: UWMC) had a February nearly as unpleasant as the weather that month. The company's shares lost a bit over 10% of their value in the short month, despite the company reporting...
Key Points The Federal Reserve cut its key rates twice during the period. It probably won't repeat that move anytime soon, however. 10 stocks we like better than UWM Holdings › Investors in mortgage lender UWM Holdings (NYSE: UWMC) had a February nearly as unpleasant as the weather that month. The company's shares lost a bit over 10% of their value in the short month, despite the company reporting record loan volumes in its fourth quarter. A major home financier UWM is the indirect parent company of Universal Wholesale Mortgage, which, as its name implies, provides mortgages to third-party sellers (mainly brokers). UWM controls the largest wholesaler, so its size and scope are considerable. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » The company posted its fourth-quarter and full-year results toward the end of the month, divulging that it originated $49.6 billion in home loans during the former period. This was up significantly from the $38.7 billion it earned in the same quarter of 2024. That filtered down to revenue of just over $945 million, for a robust year-over-year gain of 31%. As for profitability, net income not under generally accepted accounting practices (GAAP) zoomed nearly four times higher to more than $130 million, or $0.08 per share. Analysts were expecting a higher bottom-line bounce; however, their collective estimate for non-GAAP (adjusted) net income was $0.09 per share. On a brighter note, UWM beat on revenue, as the average prognosticator expectation for that line item was barely over $754 million. UWM benefited greatly from not one, but two cuts to the Federal Reserve's key interest rate during the quarter. This significantly ramped up refinancing volume, which almost doubled from both the previous and the year-ago quarters to $30.7 billion. Surges in key fundamentals d...